Enzyme therapy for pompe disease with recombinant human alpha-glucosidase from rabbit milk.
about
Hearing in adults with Pompe diseaseTherapeutic neonatal hepatic gene therapy in mucopolysaccharidosis VII dogs.Chinese hamster ovary cell-derived recombinant human acid alpha-glucosidase in infantile-onset Pompe disease.N-glycans of recombinant human acid alpha-glucosidase expressed in the milk of transgenic rabbits.Recombinant human plasma phospholipid transfer protein (PLTP) to prevent bacterial growth and to treat sepsis.Pompe disease diagnosis and management guideline.Early treatment with alglucosidase alpha prolongs long-term survival of infants with Pompe diseaseOutcome of patients with classical infantile pompe disease receiving enzyme replacement therapy in Germany.Electrocardiographic and other cardiac anomalies in beta-glucuronidase-null mice corrected by nonablative neonatal marrow transplantationDiagnosis and treatment of late-onset Pompe disease in the Middle East and North Africa region: consensus recommendations from an expert groupA conceptual disease model for adult Pompe disease.Effect of enzyme therapy and prognostic factors in 69 adults with Pompe disease: an open-label single-center study.Delivery of lysosomal enzymes for therapeutic use: glucocerebrosidase as an example.Arrhythmias in patients receiving enzyme replacement therapy for infantile Pompe disease.Impact of enzyme replacement therapy on survival in adults with Pompe disease: results from a prospective international observational studyTherapeutic approaches in glycogen storage disease type II/Pompe Disease.Inherited metabolic disorders involving the eye: a clinico-biochemical perspective.Cell microencapsulation: a potential tool for the treatment of neuronopathic lysosomal storage diseases.Ten years of the international Pompe survey: patient reported outcomes as a reliable tool for studying treated and untreated children and adults with non-classic Pompe disease.Expression systems and species used for transgenic animal bioreactors.Will GM animals follow the GM plant fate?Modulation of glycogen synthesis by RNA interference: towards a new therapeutic approach for glycogenosis type II.Diagnostic challenges for Pompe disease: an under-recognized cause of floppy baby syndrome.Plasmid-based gene transfer ameliorates visceral storage in a mouse model of Sandhoff disease.Expression and characterization of functional recombinant bovine follicle-stimulating hormone (boFSHalpha/beta) produced in the milk of transgenic rabbits.Correction/mutation of acid alpha-D-glucosidase gene by modified single-stranded oligonucleotides: in vitro and in vivo studies.Restoration of muscle functionality by genetic suppression of glycogen synthesis in a murine model of Pompe disease.Enzyme replacement therapy in an infant with Pompe's disease with severe cardiomyopathy.Long-term monitoring of patients with infantile-onset Pompe disease on enzyme replacement therapy using a urinary glucose tetrasaccharide biomarker.Brain development in infantile-onset Pompe disease treated by enzyme replacement therapy.Cardiac arrhythmias following anesthesia induction in infantile-onset Pompe disease: a case series.Effectiveness of enzyme replacement therapy in adults with late-onset Pompe disease: results from the NCS-LSD cohort study.Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease.Long-term enzyme replacement therapy for pompe disease with recombinant human alpha-glucosidase derived from chinese hamster ovary cells.
P2860
Q30470326-40391601-CF72-456A-92CF-3B825A1450BDQ30476504-B67A9FF5-CE69-409E-9D18-D8720D6944C4Q30489156-7569B0C9-B4DC-49D9-A444-214A10162DD0Q33273194-103B7AA8-F956-473D-9F58-B825866ED58FQ33780365-1EECD548-0A8E-41A3-8C79-BBBA1753B045Q34567528-F6F6ACDA-CF98-498B-A394-10D14E49118EQ35087282-15B16FA0-3191-47F5-91A1-65E71357D1A8Q35220683-A49D88DE-2C31-4F83-BA2D-FEC9D83442D0Q35735485-E26F1319-661D-4FDE-9773-08BC95B24DFEQ35809528-CBEB1B07-8DFC-42DB-A0E4-D334E08E1EDDQ36061849-320A29E2-1A6F-49F0-900D-04C281CEB053Q36459627-E9C02431-F383-4CBE-A606-ED599ACFEDB8Q36640336-E30CC8EB-6117-4B65-9801-E263D285D96BQ36730504-3B873F1B-7B2F-4565-BD07-88BFD0020DC1Q36758919-D0497FE5-59B3-48F4-A797-1F8DAABDB6A0Q37329535-56E86971-E8A6-4F28-84A5-EF541922D9D9Q37607099-2A8DED84-DCDC-4ED3-BCA7-807890BB3FCBQ37879987-0BF81004-7100-4048-A4E7-5E4CBB4BA5C2Q38238918-71E5E44F-CD00-47A6-B450-4D4C72FA967DQ39468670-2884E577-C615-41D1-8443-5A3AEA251F15Q39551210-A42D2B3F-E6E8-4F01-AC49-3C4D8B21A3B4Q39941399-4B14D3D2-E1F0-496F-8E7A-B68CBBFECE77Q40325048-ED9F3CE5-BC52-4DF9-B7A8-06960E2E2ABCQ40656536-6FF235C4-8E40-44CB-AF24-F8A19DF50560Q40703232-86CAA2B6-CBEB-47B5-B4F5-B3138D3B33B9Q42609118-8C6B50CF-D109-418C-98D2-69734DCBB6C9Q43230362-69394CA6-FA21-4571-980C-AB2DEFD6AE08Q45857972-EF494B72-A569-4712-9C49-74F8C65D5716Q45972040-BFB93108-D90E-4878-8442-3E8C276610C5Q48466555-9DFD4754-2A47-425A-A7BE-034B6B97AA02Q48587106-2A244A3E-DFA3-41AE-820F-4157827503E0Q51718537-9D5C9887-A063-460F-916D-72E38FF2DAF9Q51768443-5826614D-1DAE-4F98-AEC9-15656BD5234DQ51795429-65486689-2375-4AD6-92E3-32D56CB2BA90
P2860
Enzyme therapy for pompe disease with recombinant human alpha-glucosidase from rabbit milk.
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Enzyme therapy for pompe disea ...... -glucosidase from rabbit milk.
@ast
Enzyme therapy for pompe disea ...... -glucosidase from rabbit milk.
@en
Enzyme therapy for pompe disea ...... -glucosidase from rabbit milk.
@nl
type
label
Enzyme therapy for pompe disea ...... -glucosidase from rabbit milk.
@ast
Enzyme therapy for pompe disea ...... -glucosidase from rabbit milk.
@en
Enzyme therapy for pompe disea ...... -glucosidase from rabbit milk.
@nl
prefLabel
Enzyme therapy for pompe disea ...... -glucosidase from rabbit milk.
@ast
Enzyme therapy for pompe disea ...... -glucosidase from rabbit milk.
@en
Enzyme therapy for pompe disea ...... -glucosidase from rabbit milk.
@nl
P2093
P356
P1476
Enzyme therapy for pompe disea ...... -glucosidase from rabbit milk.
@en
P2093
Smeitink JA
Van den Hout JM
Van der Ploeg AT
de Klerk JB
P2888
P304
P356
10.1023/A:1010383421286
P577
2001-04-01T00:00:00Z
P6179
1031802796